Clorox CO /DE/ Form 4 insider transactions

Clorox EVP Stacey Grier acquired 3,364 shares of common stock through a Restricted Stock Unit grant, increasing her beneficial ownership to 23,190 shares.

Clorox's EVP and Chief Legal Officer, Angela C. Hilt, acquired 7,048 shares of common stock through a restricted stock unit grant on September 16, 2025.

Kirsten Marriner, EVP Chief Admin Officer of Clorox, acquired 7,689 shares of common stock at $124.85 per share.

Clorox EVP-Group President Chris T Hyder received a grant of 7,208 restricted stock units, vesting over four years.

Clorox EVP Nina Barton acquired 7,208 shares of common stock through Restricted Stock Units, vesting over four years, as part of a Rule 10b5-1 plan.

Clorox's EVP and Chief Operating Officer, Eric H. Reynolds, acquired 9,611 shares of common stock through a Restricted Stock Unit grant.

Clorox Company's EVP and Chief Financial Officer, Luc Bellet, acquired 7,368 shares of common stock at $124.85 per share, increasing his direct beneficial ownership to 19,546 shares.

Clorox CEO Linda J Rendle increased her beneficial ownership by 34,281 shares of common stock through a Restricted Stock Unit grant valued at approximately $4.28 million.

Clorox EVP and COO Eric H. Reynolds exercised stock options and subsequently sold a portion of his common stock holdings.

Clorox EVP Nina Barton reported a pre-planned disposition of 1,610 common shares at $126.57 per share, effective July 22, 2025, to cover tax obligations.

Clorox EVP Chris T. Hyder reported a disposition of 265 common shares to cover tax obligations related to restricted stock vesting, maintaining a significant beneficial ownership.

Clorox Co. Director Christopher J. Williams increased his beneficial ownership of the company's deferred stock units through dividend reinvestment and in lieu of quarterly director's fees, bringing his total holdings to 19,046.2446 units.

Clorox Company Director Russell J. Weiner has increased his beneficial ownership in the company by acquiring additional deferred stock units through dividend reinvestment and in lieu of director's fees.

Clorox Director Matthew J. Shattock increased his beneficial ownership of the company's deferred stock units through dividend reinvestment and receipt of director's fees in lieu of cash.

Clorox Director Stephanie Plaines increased her beneficial ownership of the company's stock through the acquisition of deferred stock units via dividend reinvestment and in lieu of director's fees.

Clorox Company Director Spencer C. Fleischer has increased his beneficial ownership of the company's common stock through the acquisition of additional deferred stock units via dividend reinvestment and in lieu of quarterly director's fees.

Clorox Company Director Pierre R. Breber acquired additional Deferred Stock Units through dividend reinvestment and in lieu of quarterly fees, significantly increasing his beneficial ownership.

Director Breber Pierre R purchased 4,000 shares of Clorox (CLX) at an average price of $136.5713 on May 7, 2025.

Luc Bellet, EVP and CFO of Clorox, acquired 2,704 shares of common stock at $147.91 per share on April 1, 2025, under a restricted stock unit plan.

Director Christopher J. Williams reports acquiring additional deferred stock units in The Clorox Company through dividend reinvestment and in lieu of quarterly director's fees.

Director Russell J. Weiner reports acquiring additional deferred stock units in The Clorox Company through dividend reinvestment and in lieu of quarterly director's fees.

Director Matthew J. Shattock reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.

Director Stephanie Plaines reports acquisition of deferred stock units in The Clorox Company through dividend reinvestment and in lieu of quarterly director's fees.

Director Spencer C. Fleischer reports acquiring deferred stock units in Clorox through dividend reinvestment and in lieu of director's fees.

Director Pierre R Breber reports acquiring deferred stock units in Clorox through dividend reinvestment and in lieu of quarterly director's fees.

Chris T Hyder, an EVP at Clorox, reported a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock.

Stacey Grier, Executive Chief of Staff at Clorox, reports the withholding of shares to cover tax obligations related to vesting restricted stock.

EVP and Chief People Officer of Clorox, Kirsten Marriner, sold shares of common stock on March 10th and 11th, 2025, under a pre-planned trading program.

Director Julia Charter reports acquisition of deferred stock units in Clorox through dividend reinvestment and an annual award.

Director A.D. David Mackay reports the acquisition of deferred stock units in Clorox through dividend reinvestment and an annual award, increasing his holdings.